Bigmar President Available to Discuss Use of Pre-Mix Drugs.Business Editors JOHNSTOWN, Ohio--(BUSINESS WIRE)--Aug. 22, 2001 Company's Swiss Subsidiary Bioren Provides IV Bags with Drugs Already Mixed - Could Avoid Errors and Fraud if Available in US
WHO: Cynthia R. May, President of Bigmar, Inc., a U.S. company that
Develops generic oncology products and through its Swiss
Subsidiary, Bioren, SA, manufactures and markets pre-mixed
IV bags...
WHAT: is available to comment on the need for consideration of this
type of drug delivery in the U.S., in light of recent news
reports of a Kansas City pharmacist diluting drugs for customers.
HOW: Ms. May can be reached at 517-797-5502 or by contacting
Bev Jedynak, at Martin Janis & Co., 312-943-1100.
Bigmar, Inc. seeks to supply world markets with a full line of high quality, affordably priced generic oncology oncology /on·col·o·gy/ (ong-kol´ah-je) the sum of knowledge regarding tumors; the study of tumors. on·col·o·gy n. products. The company has filed an application with the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. for the manufacture and sale of generic Taxol taxol Organic compound with a complex multi-ring molecule that occurs in the bark of Pacific yew trees (Taxus brevifolia). It is active against certain cancers of the lung, ovary, breast, head, and neck, disrupting cell division and interfering with separation of the nuclear in the U.S. and is awaiting response. In Switzerland, the company's subsidiary, Bioren, commands approximately 60 percent of the I.V. infusion market, and recently signed an exclusive distribution agreement with Baxter SA to market and distribute Bioren's products in this market. Of particular interest to news reporters is the fact that Bioren is believed to be the first company in the world to pre-mix drugs and package them in infusion bags, thereby eliminating mistakes and, so sadly as has been reported, fraud, in the mixing of drugs. To date, Bioren has received approvals from Swiss drug authorities to market Nitroglycerine ni·tro·glyc·er·in also ni·tro·glyc·er·ine n. A thick, pale yellow liquid, C3H5N3O9, that is explosive on concussion or exposure to sudden heat. and Bupivacaine in pre-mixed IV bags. Other drugs are under consideration for similar delivery. Bigmar is a publicly-traded company with the symbol BGMR BGMR Bigmar Inc. (stock symbol) (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :BGMR). |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion